Reply to M. Horiguchi et al
J Clin Oncol
.
2017 Oct 10;35(29):3373-3374.
doi: 10.1200/JCO.2017.74.4292.
Epub 2017 Aug 11.
Authors
James Paul
1
,
Caroline Kelly
1
,
Jon Stobo
1
,
Thomas Powles
1
Affiliation
1
James Paul, Caroline Kelly, and Jon Stobo, University of Glasgow, Glasgow, United Kingdom; and Thomas Powles, Queen Mary University of London, London, United Kingdom.
PMID:
28800270
DOI:
10.1200/JCO.2017.74.4292
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Humans
Indazoles
Paclitaxel*
Pyrimidines
Sulfonamides
Urologic Neoplasms*
Substances
Indazoles
Pyrimidines
Sulfonamides
pazopanib
Paclitaxel
Grants and funding
168954-01/Cancer Research UK/United Kingdom